Question 1

Is Ramipril/Hidroclorotiazida Krka currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Ramipril/Hidroclorotiazida Krka has 10 active shortage notices across 5 countries (United Kingdom, Ireland, Spain, Belgium, United States). Status is refreshed daily from official regulatory sources.

Question 2

Why is Ramipril/Hidroclorotiazida Krka in shortage?

Accepted Answer

Regulators attribute the current Ramipril/Hidroclorotiazida Krka shortages to supply-chain disruption, unexpected increases in demand, regulatory action. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Ramipril/Hidroclorotiazida Krka shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 27 Mar 2026 to 24 Aug 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Ramipril/Hidroclorotiazida Krka shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
United Kingdom	high	1	22 Apr 2026	24 Jul 2026	MHRA
Ireland	medium	4	30 Sept 2025	15 May 2026	HPRA
Spain

Ramipril/Hidroclorotiazida Krka shortage status

Where Ramipril/Hidroclorotiazida Krka is in shortage

Why Ramipril/Hidroclorotiazida Krka is in shortage

Recent shortage history

Frequently asked questions

Get alerted when Ramipril/Hidroclorotiazida Krka status changes